123 related articles for article (PubMed ID: 6540782)
1. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
Köpf-Maier P; Hesse A
J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
[TBL] [Abstract][Full Text] [Related]
2. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
3. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.
Köpf-Maier P; Wagner W; Liss E
J Cancer Res Clin Oncol; 1981; 102(1):21-30. PubMed ID: 7199526
[TBL] [Abstract][Full Text] [Related]
4. Titanocene dichloride--the first metallocene with cancerostatic activity.
Köpf H; Köpf-Maier P
Angew Chem Int Ed Engl; 1979 Jun; 18(6):477-8. PubMed ID: 111586
[No Abstract] [Full Text] [Related]
5. [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].
Köpf-Maier P; Hesse B; Köpf H
J Cancer Res Clin Oncol; 1980 Jan; 96(1):43-51. PubMed ID: 7188941
[TBL] [Abstract][Full Text] [Related]
6. Tumor inhibition by titanocene dichloride: first clues to the mechanism of action.
Köpf-Maier P; Köpf H
Naturwissenschaften; 1980 Aug; 67(8):415-6. PubMed ID: 7191057
[No Abstract] [Full Text] [Related]
7. [Molybdocene dichloride as an antitumor agent (author's transl)].
Köpf-Maier P; Leitner M; Voigtländer R; Köpf H
Z Naturforsch C Biosci; 1979 Dec; 34(12):1174-6. PubMed ID: 161840
[TBL] [Abstract][Full Text] [Related]
8. Micronucleated cells during the growth of the Ehrlich ascites tumour on spontaneous and by titanocenedichloride-induced conditions.
Tarillion P; Taubert G; Nenning H
Mutat Res; 1997 Mar; 389(2-3):213-8. PubMed ID: 9093386
[TBL] [Abstract][Full Text] [Related]
9. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
Köpf-Maier P; Moormann A; Köpf H
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
[TBL] [Abstract][Full Text] [Related]
10. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
Valadares MC; Queiroz ML
Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
[TBL] [Abstract][Full Text] [Related]
11. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
Razin BV; Inzhevatkin EV; Nefedova VV; Egorova AB; Kazbanov VI; Nefedov VP
Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
[TBL] [Abstract][Full Text] [Related]
12. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
Köpf-Maier P; Wagner W; Hesse B; Köpf H
Eur J Cancer (1965); 1981 Jun; 17(6):665-9. PubMed ID: 7308264
[No Abstract] [Full Text] [Related]
13. Synergism between propolis and hyperthermal intraperitoneal chemotherapy with cisplatin on ehrlich ascites tumor in mice.
Oršolić N; Car N; Lisičić D; Benković V; Knežević AH; Dikić D; Petrik J
J Pharm Sci; 2013 Dec; 102(12):4395-405. PubMed ID: 24136132
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro.
Köpf-Maier P; Wagner W; Liss E
J Cancer Res Clin Oncol; 1983; 106(1):44-52. PubMed ID: 6684118
[TBL] [Abstract][Full Text] [Related]
15. Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.
Köpf-Maier P; Hesse B; Voigtländer R; Köpf H
J Cancer Res Clin Oncol; 1980; 97(1):31-9. PubMed ID: 7400205
[TBL] [Abstract][Full Text] [Related]
16. Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumour progression.
Valadares MC; Klein SI; Queiroz ML
Eur J Pharmacol; 2004 Oct; 503(1-3):203-8. PubMed ID: 15496315
[TBL] [Abstract][Full Text] [Related]
17. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
18. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
[TBL] [Abstract][Full Text] [Related]
19. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
20. [Histomorphologic changes in Jensen sarcoma following radiotherapy, titanocene dichloride treatment and combination therapy].
Uhl J; Langrock K; Krieghoff B; Hambsch K
Radiobiol Radiother (Berl); 1987; 28(1):51-7. PubMed ID: 3588859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
